Search

everythinglearnresearchcommunity

for

Search:↓

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

Different prostate cancer treatments have similar risks of secondary cancers and related mortality when considering patient age and smoking history.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

More prostate biopsies increase the chance of finding cancers that may not need treatment.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

Genetic testing for cancer risk can lead to early and life-saving treatments in people without symptoms.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Chemotherapy significantly lowers Inhibin A levels in breast cancer patients.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

Some breast cancer chemotherapy can cause permanent hair loss.

The study found that urine metabolites M1b or M4 are the best indicators of ATD use in horses, with detection possible up to 77 hours in urine and 28 hours in blood.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

A new method accurately measures phenolic compounds in Ziziphus Jujuba extract quickly and efficiently.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Core symptoms in breast cancer chemotherapy remain stable, aiding targeted interventions.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Finasteride breakdown products found in bile and urine, helps understand drug safety and effectiveness.

New method measures finasteride in plasma, finds two formulations bioequivalent.

Understanding breast cancer requires considering both medical advancements and social influences.

Higher cholesterol levels increase aggressive prostate cancer risk.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.